Sets Lead Plaintiff Deadline of March 28, 2017
Levi & Korsinsky, LLP announced that it has commenced a class action in the USDC for the Eastern District of Pennsylvania on behalf of shareholders of Egalet Corporation (“Egalet” or the “Company”) (NASDAQ: EGLT) who purchased shares between December 15, 2015 and January 9, 2017.
The complaint alleges that, among other allegations, throughout the Class Period, Egalet made materially false and/or misleading statements concerning its lead product, ARYMO ER and the likelihood the product would receive oral abuse-deterrent labeling.
The case, Mineff v. Egalet Corporation, et al. (No. 2:17-cv-00390-MMB) was filed on January 27, 2017 and is available for review here:
To get more information go to: http://zlk.9nl.com/egalet
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
Take Action: if you suffered a loss in Egalet you have until March 28, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky LLP encourages anyone with information regarding Egalet’s conduct to contact us, including whistleblowers, former employees, shareholders and others.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
